Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum-Reference-Cited by-同舟云学术

Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum

Published:1988-08 Issue:2 Volume:95 Page:289-294
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Lanza Frank L.,Aspinall Richard L.,Swabb Edward A.,Davis Robert E.,Rack Mary F.,Rubin Abbe

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents;Lanza;Am J Med,1984

2. A review of upper gastrointestinal effects of the newer nonsteroidal anti-inflammatory agents;Pemberton;Dig Dis Sci,1979

3. An endoscopic evaluation of the effects of nonsteroidal anti-inflammatory drugs on the gastric mucosa;Lanza;Gastrointest Endosc,1975

4. The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers;Lanza;Dig Dis Sci,1979

5. Endoscopic evaluation of the effects of aspirin, buffered aspirin and enteric-coated aspirin on gastric and duodenal mucosa;Lanza;N Engl J Med,1980

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive value of gastrointestinal symptoms and patient risk factors for NSAID-associated gastrointestinal ulcers defined by endoscopy? Insights from a pooled analysis of two naproxen clinical trials;PLOS ONE;2023-04-13

2. A directional measure for marginal homogeneity in square contingency tables with ordered categories;Biometrical Letters;2019-06-01

3. Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease;Expert Opinion on Pharmacotherapy;2016-12-20

4. Gastrointestinal Adverse Reactions from Ibuprofen;Ibuprofen;2015-07-03

5. PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers;Expert Review of Cardiovascular Therapy;2014-10-10